WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Down 81.8% in July

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a significant decrease in short interest during the month of July. As of July 31st, there was short interest totaling 46,353 shares, a decrease of 81.8% from the July 15th total of 255,103 shares. Based on an average trading volume of 113,253 shares, the short-interest ratio is currently 0.4 days. Currently, 0.0% of the company’s shares are sold short.

WuXi Biologics (Cayman) Stock Performance

WuXi Biologics (Cayman) stock opened at $11.64 on Thursday. WuXi Biologics has a 52-week low of $7.30 and a 52-week high of $11.88. The firm has a 50 day moving average price of $9.23 and a two-hundred day moving average price of $9.15.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.